Hey Chunky Salsa, I'm obviously not even a stock market novus.
However, maybe people will buy MATN/OXGN stock now, because it's at such a low value, so based on that, you'd think that the only way is up.
I'm not a MATN pumper, but I would think they would have to partner or sell in order to keep things going, since the reverse splits kept getting voted down, by the share holders.
As far as I know, MATN has a orphan designation on one of their protocols and that 2 patients went into complete remission after having tried other treatments.
I would guess that after more successful patient trial data, that MATN would increase by a lot, due to the new/additional market potential and due to a sale or merger of MATN?
It's hard to catch a falling knife, but I would think that MATN is almost as low as it will go now.
Apparently, MATN is trading at a level, below cash value?
I wish the experts from the other message boards would chime in here on this board.
News 
Market Data 
Discover 
